Prediction of durable response upon treatment with immune checkpoint inhibitors in melanoma

被引：0
|
作者：
Persa, O. [1 ,2 ]
Helbig, D. [2 ]
Schlaak, M. [3 ]
Biedermann, T. [1 ]
Noh, K. [4 ]
机构：
[1] Tech Univ Munich, Dept Dermatol & Allergol, D-80802 Munich, Germany
[2] Univ Cologne, Dept Dermatol & Venerol, Cologne, Germany
[3] Charite Univ Med Berlin, Dept Dermatol & Venerol, Berlin, Germany
[4] Univ Cologne, Dept Pathol, Cologne, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2024年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P201
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Correlation of DNA methylation signatures with response to immune checkpoint inhibitors in metastatic melanoma
    Ressler, Julia Maria
    Tomasich, Erwin
    Hatziioannou, Teresa
    Ringl, Helmut
    Heller, Gerwin
    Silmbrod, Rita
    Zila, Nina
    Tschandl, Philipp
    Hoeller, Christoph
    Berghoff, Anna Sophie
    Preusser, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Immune Checkpoint Inhibitors in Melanoma: A Review of Pharmacokinetics and Exposure-Response Relationships
    Leven, Cyril
    Padelli, Mael
    Carre, Jean-Luc
    Bellissant, Eric
    Misery, Laurent
    CLINICAL PHARMACOKINETICS, 2019, 58 (11) : 1393 - 1405
  • [43] Identifying determinants of melanoma response to immune checkpoint inhibitors via preclinical modeling
    Day, Chi-Ping
    El Meskini, Rajaa
    Graff-Cherry, Carl
    Michalowski, Aleksandra
    Ohler, Zoe Weaver
    Van Dyke, Terry
    Merlino, Glenn
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [44] DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic Melanoma
    Ressler, Julia Maria
    Tomasich, Erwin
    Hatziioannou, Teresa
    Ringl, Helmut
    Heller, Gerwin
    Silmbrod, Rita
    Gottmann, Lynn
    Starzer, Angelika Martina
    Zila, Nina
    Tschandl, Philipp
    Hoeller, Christoph
    Preusser, Matthias
    Berghoff, Anna Sophie
    TARGETED ONCOLOGY, 2024, 19 (02) : 263 - 275
  • [45] Development of leukoderma as an indicator of clinical response to immune checkpoint inhibitors in melanoma patients
    Verkhovskaia, Sofia
    Di Pietro, Francesca Romana
    Mastroeni, Simona
    Carbone, Maria Luigia
    Abeni, Damiano
    Morese, Roberto
    Morelli, Francesca Maria
    Carlo, Gian
    Cappellini, Antonini
    D'Atri, Stefania
    Marchetti, Paolo
    De Galitiis, Federica
    Failla, Cristina Maria
    Fortes, Cristina
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (SUPPL 1)
  • [46] DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic Melanoma
    Julia Maria Ressler
    Erwin Tomasich
    Teresa Hatziioannou
    Helmut Ringl
    Gerwin Heller
    Rita Silmbrod
    Lynn Gottmann
    Angelika Martina Starzer
    Nina Zila
    Philipp Tschandl
    Christoph Hoeller
    Matthias Preusser
    Anna Sophie Berghoff
    Targeted Oncology, 2024, 19 : 263 - 275
  • [47] Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma
    Xu, Ying
    Wang, Zheng
    Li, Fufeng
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [48] Biomarkers for Outcome in Metastatic Melanoma in First Line Treatment with Immune Checkpoint Inhibitors
    Mesti, Tanja
    Grasic Kuhar, Cvetka
    Ocvirk, Janja
    BIOMEDICINES, 2023, 11 (03)
  • [49] A Single Institutional Experience of Immune Checkpoint Inhibitors in the Treatment of Advanced Mucosal Melanoma
    Kuo, James C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 147 - 147
  • [50] Caloric restriction mimetics as adjuvant to immune checkpoint inhibitors for treatment of melanoma.
    Morehead, Lauren C.
    Koss, Brian S.
    Wallis, Katherine F.
    Tackett, Alan J.
    Miousse, Isabelle Racine
    CANCER RESEARCH, 2021, 81 (13)
12345